Here's some of what is coming soon to NeurologyLive® this week.
|Slideshows|June 11, 2019
Neurology News: Alzheimer Disease, MS, and More
Author(s)Leo Robert
Alzheimer and circulating cholesterol linked, obesity has a big impact on MS, mild traumatic brain injury difficulties persist, and other recent findings are summarized here.
Advertisement
Advertisement
Related to this article
The phase 3 TRONTIER 1 and 2 trials will test whether trontinemab's faster brain entry and rapid amyloid clearance translate into slower clinical decline in early Alzheimer disease.
Joanna Wardlaw, MD, Professor of Applied Neuroimaging at the University of Edinburgh, discusses the evolving understanding of cerebral small vessel disease, emerging therapeutic approaches, and the makings behind a successful trial.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 23, 2026.
Fast track status covers AV-1959R, an investigational amyloid-beta vaccine, for preventing Alzheimer disease in cognitively unimpaired adults with amyloid pathology.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding Cemdisiran's Mechanism of Action in Myasthenia Gravis
2
Zola-Cel and Treatment-Free Remission: What the BREAKFREE-2 Data Show
3
FDA Grants Priority Review to Huntington Disease Gene Therapy BLA
4
Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy
5